Rameh Lucia E, York John D, Blind Raymond D
Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile, Alabama, USA; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
J Biol Chem. 2025 Feb;301(2):108095. doi: 10.1016/j.jbc.2024.108095. Epub 2024 Dec 18.
Mechanistic target of rapamycin (mTOR) binds the small metabolite inositol hexakisphosphate (IP) as shown in structures of mTOR; however, it remains unclear if IP, or any other inositol phosphate species, function as an integral structural element(s) or catalytic regulator(s) of mTOR. Here, we show that multiple, exogenously added inositol phosphate species can enhance the ability of mTOR and mechanistic target of rapmycin complex 1 (mTORC1) to phosphorylate itself and peptide substrates in in vitro kinase reactions, with the higher order phosphorylated species being more potent (IP = IP > IP >> IP). IP increased the V and decreased the apparent K of mTOR for ATP. Although IP did not affect the apparent K of mTORC1 for ATP, monitoring kinase activity over longer reaction times showed increased product formation, suggesting inositol phosphates stabilize the active form of mTORC1 in vitro. The effects of IP on mTOR were reversible, suggesting IP bound to mTOR can be exchanged dynamically with the free solvent. Interestingly, we also observed that IP could alter mTOR electrophoretic mobility under denaturing conditions and its solubility in the presence of manganese. Together, these data suggest for the first time that multiple inositol phosphate species (IP, IP, IP, and to a lesser extent IP) can dynamically regulate mTOR and mTORC1 by promoting a stable, more soluble active state of the kinase. Our data suggest that studies of the dynamics of inositol phosphate regulation of mTOR in cells are well justified.
雷帕霉素作用机制靶点(mTOR)结合小分子代谢物肌醇六磷酸(IP),如mTOR的结构所示;然而,IP或任何其他肌醇磷酸是否作为mTOR的完整结构元件或催化调节因子仍不清楚。在此,我们表明,在体外激酶反应中,多种外源添加的肌醇磷酸可以增强mTOR和雷帕霉素作用机制靶点复合物1(mTORC1)自身磷酸化和磷酸化肽底物的能力,高阶磷酸化物种的作用更强(IP₆>IP₅>IP₄>>IP₃)。IP增加了mTOR对ATP的Vmax并降低了表观Km。虽然IP不影响mTORC1对ATP的表观Km,但在更长反应时间监测激酶活性显示产物形成增加,这表明肌醇磷酸在体外稳定了mTORC1的活性形式。IP对mTOR的作用是可逆的,表明与mTOR结合的IP可以与游离溶剂动态交换。有趣的是,我们还观察到IP可以在变性条件下改变mTOR的电泳迁移率及其在锰存在下的溶解度。总之,这些数据首次表明多种肌醇磷酸物种(IP₆、IP₅、IP₄以及程度较轻的IP₃)可以通过促进激酶稳定、更易溶的活性状态来动态调节mTOR和mTORC1。我们的数据表明对细胞中mTOR的肌醇磷酸调节动力学进行研究是很有必要的。